Healthcare News - An Overview
FTC sues significant pharmacy profit managers above insulin rates The agency introduced action towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist price of lifestyle-preserving insulin prescription drugs.This system aligns with those initiativ